APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lansoprazole

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lansoprazole Industry Growth and Trends Forecast to 2032

20 December 2025115 pages

Choose your research edition.

Industry ResearchLansoprazole Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Lansoprazole Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Lansoprazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lansoprazole Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Lansoprazole Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Lansoprazole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lansoprazole include Takeda Pharmaceutical, Teva Pharms, Suzhou YUSHI Pharmaceutical Co., Sandoz, Nang Kuang Pharmaceutical, Mylan, Luoxin Biotechnology, Pfizer and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lansoprazole market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lansoprazole market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lansoprazole market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lansoprazole.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lansoprazole market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lansoprazole Market by Company

Takeda Pharmaceutical

Teva Pharms

Suzhou YUSHI Pharmaceutical Co.

Sandoz

Nang Kuang Pharmaceutical

Mylan

Luoxin Biotechnology

Pfizer

GSK

Changzhou Siyao Pharmaceuticals

Beijing Honglin Pharma.

Youcare Pharmaceutical Group

Taj Pharma

Sun Pharmaceutical Industries

Lepu Pharmaceuticals

Krka

HOPE PHARMA

Dr. Reddy's

Cisen Pharmaceutical

Lansoprazole Segment by Type

Injection

Tablets

Capsules

Lansoprazole Segment by Application

Male

Female

Lansoprazole Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lansoprazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lansoprazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lansoprazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lansoprazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lansoprazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Tablets Table 3. Major Company of Capsules Table 4. Global Lansoprazole Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lansoprazole Sales by Type (2021-2026) & (W Units) Table 6. Global Lansoprazole Sales Market Share in Volume by Type (2021-2026) Table 7. Global Lansoprazole Sales by Type (2021-2026) & (US$ Million) Table 8. Global Lansoprazole Sales Market Share in Value by Type (2021-2026) Table 9. Global Lansoprazole Price by Type (2021-2026) & (US$/Unit) Table 10. Global Lansoprazole Sales by Type (2027-2032) & (W Units) Table 11. Global Lansoprazole Sales Market Share in Volume by Type (2027-2032) Table 12. Global Lansoprazole Sales by Type (2027-2032) & (US$ Million) Table 13. Global Lansoprazole Sales Market Share in Value by Type (2027-2032) Table 14. Global Lansoprazole Price by Type (2027-2032) & (US$/Unit) Table 15. North America Lansoprazole Sales by Type (2021-2026) & (W Units) Table 16. North America Lansoprazole Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Lansoprazole Sales by Type (2021-2026) & (W Units) Table 18. Europe Lansoprazole Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Lansoprazole Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Lansoprazole Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Lansoprazole Sales by Type (2021-2026) & (W Units) Table 22. Latin America Lansoprazole Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Lansoprazole Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Lansoprazole Sales by Type (2021-2026) & (US$ Million) Table 25. Lansoprazole Industry Trends Table 26. Lansoprazole Industry Drivers Table 27. Lansoprazole Industry Opportunities and Challenges Table 28. Lansoprazole Industry Restraints Table 29. Global Lansoprazole Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Lansoprazole Revenue Market Share by Company (2021-2026) Table 31. Global Lansoprazole Sales by Company (2021-2026) & (W Units) Table 32. Global Lansoprazole Sales Share by Company (2021-2026) Table 33. Global Lansoprazole Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Lansoprazole Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Lansoprazole Major Company Production Sites and Headquarters Table 36. Global Lansoprazole Company, Product Type & Application Table 37. Global Lansoprazole Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Lansoprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Lansoprazole Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Lansoprazole Sales by Region (2021-2026) & (W Units) Table 42. Global Lansoprazole Sales Market Share in Volume by Region (2021-2026) Table 43. Global Lansoprazole Sales by Region (2021-2026) & (US$ Million) Table 44. Global Lansoprazole Sales Market Share in Value by Region (2021-2026) Table 45. Global Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Lansoprazole Sales by Region (2027-2032) & (W Units) Table 47. Global Lansoprazole Sales Market Share in Volume by Region (2027-2032) Table 48. Global Lansoprazole Sales by Region (2027-2032) & (US$ Million) Table 49. Global Lansoprazole Sales Market Share in Value by Region (2027-2032) Table 50. Global Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Lansoprazole Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Lansoprazole Sales by Application (2021-2026) & (W Units) Table 53. Global Lansoprazole Sales Market Share in Volume by Application (2021-2026) Table 54. Global Lansoprazole Sales by Application (2021-2026) & (US$ Million) Table 55. Global Lansoprazole Sales Market Share in Value by Application (2021-2026) Table 56. Global Lansoprazole Price by Application (2021-2026) & (US$/Unit) Table 57. Global Lansoprazole Sales by Application (2027-2032) & (W Units) Table 58. Global Lansoprazole Sales Market Share in Volume by Application (2027-2032) Table 59. Global Lansoprazole Sales by Application (2027-2032) & (US$ Million) Table 60. Global Lansoprazole Sales Market Share in Value by Application (2027-2032) Table 61. Global Lansoprazole Price by Application (2027-2032) & (US$/Unit) Table 62. North America Lansoprazole Sales by Application (2021-2026) & (W Units) Table 63. North America Lansoprazole Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Lansoprazole Sales by Application (2021-2026) & (W Units) Table 65. Europe Lansoprazole Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Lansoprazole Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Lansoprazole Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Lansoprazole Sales by Application (2021-2026) & (W Units) Table 69. Latin America Lansoprazole Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Lansoprazole Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Lansoprazole Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Pharmaceutical Company Information Table 73. Takeda Pharmaceutical Business Overview Table 74. Takeda Pharmaceutical Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Takeda Pharmaceutical Lansoprazole Product Portfolio Table 76. Takeda Pharmaceutical Recent Development Table 77. Teva Pharms Company Information Table 78. Teva Pharms Business Overview Table 79. Teva Pharms Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Teva Pharms Lansoprazole Product Portfolio Table 81. Teva Pharms Recent Development Table 82. Suzhou YUSHI Pharmaceutical Co. Company Information Table 83. Suzhou YUSHI Pharmaceutical Co. Business Overview Table 84. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio Table 86. Suzhou YUSHI Pharmaceutical Co. Recent Development Table 87. Sandoz Company Information Table 88. Sandoz Business Overview Table 89. Sandoz Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sandoz Lansoprazole Product Portfolio Table 91. Sandoz Recent Development Table 92. Nang Kuang Pharmaceutical Company Information Table 93. Nang Kuang Pharmaceutical Business Overview Table 94. Nang Kuang Pharmaceutical Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Nang Kuang Pharmaceutical Lansoprazole Product Portfolio Table 96. Nang Kuang Pharmaceutical Recent Development Table 97. Mylan Company Information Table 98. Mylan Business Overview Table 99. Mylan Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Mylan Lansoprazole Product Portfolio Table 101. Mylan Recent Development Table 102. Luoxin Biotechnology Company Information Table 103. Luoxin Biotechnology Business Overview Table 104. Luoxin Biotechnology Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Luoxin Biotechnology Lansoprazole Product Portfolio Table 106. Luoxin Biotechnology Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer Lansoprazole Product Portfolio Table 111. Pfizer Recent Development Table 112. GSK Company Information Table 113. GSK Business Overview Table 114. GSK Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GSK Lansoprazole Product Portfolio Table 116. GSK Recent Development Table 117. Changzhou Siyao Pharmaceuticals Company Information Table 118. Changzhou Siyao Pharmaceuticals Business Overview Table 119. Changzhou Siyao Pharmaceuticals Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio Table 121. Changzhou Siyao Pharmaceuticals Recent Development Table 122. Beijing Honglin Pharma. Company Information Table 123. Beijing Honglin Pharma. Business Overview Table 124. Beijing Honglin Pharma. Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Beijing Honglin Pharma. Lansoprazole Product Portfolio Table 126. Beijing Honglin Pharma. Recent Development Table 127. Youcare Pharmaceutical Group Company Information Table 128. Youcare Pharmaceutical Group Business Overview Table 129. Youcare Pharmaceutical Group Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Youcare Pharmaceutical Group Lansoprazole Product Portfolio Table 131. Youcare Pharmaceutical Group Recent Development Table 132. Taj Pharma Company Information Table 133. Taj Pharma Business Overview Table 134. Taj Pharma Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Taj Pharma Lansoprazole Product Portfolio Table 136. Taj Pharma Recent Development Table 137. Sun Pharmaceutical Industries Company Information Table 138. Sun Pharmaceutical Industries Business Overview Table 139. Sun Pharmaceutical Industries Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Sun Pharmaceutical Industries Lansoprazole Product Portfolio Table 141. Sun Pharmaceutical Industries Recent Development Table 142. Lepu Pharmaceuticals Company Information Table 143. Lepu Pharmaceuticals Business Overview Table 144. Lepu Pharmaceuticals Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Lepu Pharmaceuticals Lansoprazole Product Portfolio Table 146. Lepu Pharmaceuticals Recent Development Table 147. Krka Company Information Table 148. Krka Business Overview Table 149. Krka Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Krka Lansoprazole Product Portfolio Table 151. Krka Recent Development Table 152. HOPE PHARMA Company Information Table 153. HOPE PHARMA Business Overview Table 154. HOPE PHARMA Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. HOPE PHARMA Lansoprazole Product Portfolio Table 156. HOPE PHARMA Recent Development Table 157. Dr. Reddy's Company Information Table 158. Dr. Reddy's Business Overview Table 159. Dr. Reddy's Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Dr. Reddy's Lansoprazole Product Portfolio Table 161. Dr. Reddy's Recent Development Table 162. Cisen Pharmaceutical Company Information Table 163. Cisen Pharmaceutical Business Overview Table 164. Cisen Pharmaceutical Lansoprazole Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Cisen Pharmaceutical Lansoprazole Product Portfolio Table 166. Cisen Pharmaceutical Recent Development Table 167. North America Lansoprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 168. North America Lansoprazole Sales by Country (2021-2026) & (W Units) Table 169. North America Lansoprazole Sales Market Share by Country (2021-2026) Table 170. North America Lansoprazole Sales Forecast by Country (2027-2032) & (W Units) Table 171. North America Lansoprazole Sales Market Share Forecast by Country (2027-2032) Table 172. North America Lansoprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. North America Lansoprazole Market Size by Country (2021-2026) & (US$ Million) Table 174. North America Lansoprazole Market Share by Country (2021-2026) Table 175. North America Lansoprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. North America Lansoprazole Market Share Forecast by Country (2027-2032) Table 177. Europe Lansoprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 178. Europe Lansoprazole Sales by Country (2021-2026) & (W Units) Table 179. Europe Lansoprazole Sales Market Share by Country (2021-2026) Table 180. Europe Lansoprazole Sales Forecast by Country (2027-2032) & (W Units) Table 181. Europe Lansoprazole Sales Market Share Forecast by Country (2027-2032) Table 182. Europe Lansoprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Europe Lansoprazole Market Size by Country (2021-2026) & (US$ Million) Table 184. Europe Lansoprazole Market Share by Country (2021-2026) Table 185. Europe Lansoprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Europe Lansoprazole Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific Lansoprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific Lansoprazole Sales by Country (2021-2026) & (W Units) Table 189. Asia-Pacific Lansoprazole Sales Market Share by Country (2021-2026) Table 190. Asia-Pacific Lansoprazole Sales Forecast by Country (2027-2032) & (W Units) Table 191. Asia-Pacific Lansoprazole Sales Market Share Forecast by Country (2027-2032) Table 192. Asia-Pacific Lansoprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Asia-Pacific Lansoprazole Market Size by Country (2021-2026) & (US$ Million) Table 194. Asia-Pacific Lansoprazole Market Share by Country (2021-2026) Table 195. Asia-Pacific Lansoprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Asia-Pacific Lansoprazole Market Share Forecast by Country (2027-2032) Table 197. Latin America Lansoprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 198. Latin America Lansoprazole Sales by Country (2021-2026) & (W Units) Table 199. Latin America Lansoprazole Sales Market Share by Country (2021-2026) Table 200. Latin America Lansoprazole Sales Forecast by Country (2027-2032) & (W Units) Table 201. Latin America Lansoprazole Sales Market Share Forecast by Country (2027-2032) Table 202. Latin America Lansoprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Latin America Lansoprazole Market Size by Country (2021-2026) & (US$ Million) Table 204. Latin America Lansoprazole Market Share by Country (2021-2026) Table 205. Latin America Lansoprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Latin America Lansoprazole Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa Lansoprazole Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa Lansoprazole Sales by Country (2021-2026) & (W Units) Table 209. Middle East and Africa Lansoprazole Sales Market Share by Country (2021-2026) Table 210. Middle East and Africa Lansoprazole Sales Forecast by Country (2027-2032) & (W Units) Table 211. Middle East and Africa Lansoprazole Sales Market Share Forecast by Country (2027-2032) Table 212. Middle East and Africa Lansoprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Middle East and Africa Lansoprazole Market Size by Country (2021-2026) & (US$ Million) Table 214. Middle East and Africa Lansoprazole Market Share by Country (2021-2026) Table 215. Middle East and Africa Lansoprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Middle East and Africa Lansoprazole Market Share Forecast by Country (2027-2032) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Lansoprazole Distributors List Table 220. Lansoprazole Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Lansoprazole Image Figure 2. Global Lansoprazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lansoprazole Market Size (2021-2032) & (US$ Million) Figure 4. Global Lansoprazole Sales (2021-2032) & (W Units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (W Units) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 9. Capsules Image Figure 10. Global Capsules Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Lansoprazole Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Lansoprazole Market Share by Type 2025 VS 2032 Figure 13. North America Lansoprazole Sales Market Share in Volume by Type in 2025 Figure 14. North America Lansoprazole Sales Market Share in Value by Type in 2025 Figure 15. Europe Lansoprazole Sales Market Share in Volume by Type in 2025 Figure 16. Europe Lansoprazole Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Lansoprazole Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Lansoprazole Sales Market Share in Value by Type in 2025 Figure 19. Latin America Lansoprazole Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Lansoprazole Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Lansoprazole Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Lansoprazole Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Lansoprazole Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Male Image Figure 26. Global Male Sales YoY Growth (2021-2032) & (W Units) Figure 27. Female Image Figure 28. Global Female Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Lansoprazole Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Lansoprazole Market Share by Application 2025 VS 2032 Figure 31. North America Lansoprazole Sales Market Share in Volume by Application in 2025 Figure 32. North America Lansoprazole Sales Market Share in Value by Application in 2025 Figure 33. Europe Lansoprazole Sales Market Share in Volume by Application in 2025 Figure 34. Europe Lansoprazole Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Lansoprazole Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Lansoprazole Sales Market Share in Value by Application in 2025 Figure 37. Latin America Lansoprazole Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Lansoprazole Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Lansoprazole Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Lansoprazole Sales Market Share in Value by Application in 2025 Figure 41. North America Lansoprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Lansoprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Lansoprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lansoprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Lansoprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Lansoprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Lansoprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Lansoprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Lansoprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lansoprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Lansoprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Lansoprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Lansoprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Lansoprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Lansoprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Lansoprazole Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Lansoprazole Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablets
  • Capsules
Applications
  • Male
  • Female
Companies covered
  • Takeda Pharmaceutical
  • Teva Pharms
  • Suzhou YUSHI Pharmaceutical Co.
  • Sandoz
  • Nang Kuang Pharmaceutical
  • Mylan
  • Luoxin Biotechnology
  • Pfizer
  • GSK
  • Changzhou Siyao Pharmaceuticals
  • Beijing Honglin Pharma.
  • Youcare Pharmaceutical Group
  • Taj Pharma
  • Sun Pharmaceutical Industries
  • Lepu Pharmaceuticals
  • Krka
  • HOPE PHARMA
  • Dr. Reddy's
  • Cisen Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lansoprazole Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lansoprazole Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lansoprazole Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Tablets
  8. 1.3.3 Capsules
  9. 1.4 Global Lansoprazole Market Size by Type
  10. 1.4.1 Global Lansoprazole Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Lansoprazole Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Lansoprazole Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Lansoprazole Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Lansoprazole Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Lansoprazole Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Lansoprazole Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Lansoprazole Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lansoprazole Industry Trends
  2. 2.2 Lansoprazole Industry Drivers
  3. 2.3 Lansoprazole Industry Opportunities and Challenges
  4. 2.4 Lansoprazole Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lansoprazole Revenue (2021-2026)
  2. 3.2 Global Top Players by Lansoprazole Sales (2021-2026)
  3. 3.3 Global Top Players by Lansoprazole Price (2021-2026)
  4. 3.4 Global Lansoprazole Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lansoprazole Major Company Production Sites & Headquarters
  6. 3.6 Global Lansoprazole Company, Product Type & Application
  7. 3.7 Global Lansoprazole Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lansoprazole Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lansoprazole Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lansoprazole Tier 1, Tier 2, and Tier 3
4 Lansoprazole Regional Status and Outlook
  1. 4.1 Global Lansoprazole Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lansoprazole Historic Market Size by Region
  3. 4.2.1 Global Lansoprazole Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lansoprazole Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lansoprazole Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lansoprazole Forecasted Market Size by Region
  7. 4.3.1 Global Lansoprazole Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lansoprazole Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lansoprazole Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lansoprazole by Application
  1. 5.1 Lansoprazole Market by Application
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Lansoprazole Market Size by Application
  5. 5.2.1 Global Lansoprazole Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Lansoprazole Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Lansoprazole Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Lansoprazole Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Lansoprazole Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Lansoprazole Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Lansoprazole Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Lansoprazole Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Lansoprazole Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 Teva Pharms
  8. 6.2.1 Teva Pharms Company Information
  9. 6.2.2 Teva Pharms Business Overview
  10. 6.2.3 Teva Pharms Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharms Lansoprazole Product Portfolio
  12. 6.2.5 Teva Pharms Recent Developments
  13. 6.3 Suzhou YUSHI Pharmaceutical Co.
  14. 6.3.1 Suzhou YUSHI Pharmaceutical Co. Company Information
  15. 6.3.2 Suzhou YUSHI Pharmaceutical Co. Business Overview
  16. 6.3.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio
  18. 6.3.5 Suzhou YUSHI Pharmaceutical Co. Recent Developments
  19. 6.4 Sandoz
  20. 6.4.1 Sandoz Company Information
  21. 6.4.2 Sandoz Business Overview
  22. 6.4.3 Sandoz Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sandoz Lansoprazole Product Portfolio
  24. 6.4.5 Sandoz Recent Developments
  25. 6.5 Nang Kuang Pharmaceutical
  26. 6.5.1 Nang Kuang Pharmaceutical Company Information
  27. 6.5.2 Nang Kuang Pharmaceutical Business Overview
  28. 6.5.3 Nang Kuang Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nang Kuang Pharmaceutical Lansoprazole Product Portfolio
  30. 6.5.5 Nang Kuang Pharmaceutical Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mylan Lansoprazole Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Luoxin Biotechnology
  38. 6.7.1 Luoxin Biotechnology Company Information
  39. 6.7.2 Luoxin Biotechnology Business Overview
  40. 6.7.3 Luoxin Biotechnology Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Luoxin Biotechnology Lansoprazole Product Portfolio
  42. 6.7.5 Luoxin Biotechnology Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Lansoprazole Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 GSK
  50. 6.9.1 GSK Company Information
  51. 6.9.2 GSK Business Overview
  52. 6.9.3 GSK Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GSK Lansoprazole Product Portfolio
  54. 6.9.5 GSK Recent Developments
  55. 6.10 Changzhou Siyao Pharmaceuticals
  56. 6.10.1 Changzhou Siyao Pharmaceuticals Company Information
  57. 6.10.2 Changzhou Siyao Pharmaceuticals Business Overview
  58. 6.10.3 Changzhou Siyao Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio
  60. 6.10.5 Changzhou Siyao Pharmaceuticals Recent Developments
  61. 6.11 Beijing Honglin Pharma.
  62. 6.11.1 Beijing Honglin Pharma. Company Information
  63. 6.11.2 Beijing Honglin Pharma. Business Overview
  64. 6.11.3 Beijing Honglin Pharma. Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Beijing Honglin Pharma. Lansoprazole Product Portfolio
  66. 6.11.5 Beijing Honglin Pharma. Recent Developments
  67. 6.12 Youcare Pharmaceutical Group
  68. 6.12.1 Youcare Pharmaceutical Group Company Information
  69. 6.12.2 Youcare Pharmaceutical Group Business Overview
  70. 6.12.3 Youcare Pharmaceutical Group Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Youcare Pharmaceutical Group Lansoprazole Product Portfolio
  72. 6.12.5 Youcare Pharmaceutical Group Recent Developments
  73. 6.13 Taj Pharma
  74. 6.13.1 Taj Pharma Company Information
  75. 6.13.2 Taj Pharma Business Overview
  76. 6.13.3 Taj Pharma Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Taj Pharma Lansoprazole Product Portfolio
  78. 6.13.5 Taj Pharma Recent Developments
  79. 6.14 Sun Pharmaceutical Industries
  80. 6.14.1 Sun Pharmaceutical Industries Company Information
  81. 6.14.2 Sun Pharmaceutical Industries Business Overview
  82. 6.14.3 Sun Pharmaceutical Industries Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sun Pharmaceutical Industries Lansoprazole Product Portfolio
  84. 6.14.5 Sun Pharmaceutical Industries Recent Developments
  85. 6.15 Lepu Pharmaceuticals
  86. 6.15.1 Lepu Pharmaceuticals Company Information
  87. 6.15.2 Lepu Pharmaceuticals Business Overview
  88. 6.15.3 Lepu Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Lepu Pharmaceuticals Lansoprazole Product Portfolio
  90. 6.15.5 Lepu Pharmaceuticals Recent Developments
  91. 6.16 Krka
  92. 6.16.1 Krka Company Information
  93. 6.16.2 Krka Business Overview
  94. 6.16.3 Krka Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Krka Lansoprazole Product Portfolio
  96. 6.16.5 Krka Recent Developments
  97. 6.17 HOPE PHARMA
  98. 6.17.1 HOPE PHARMA Company Information
  99. 6.17.2 HOPE PHARMA Business Overview
  100. 6.17.3 HOPE PHARMA Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 HOPE PHARMA Lansoprazole Product Portfolio
  102. 6.17.5 HOPE PHARMA Recent Developments
  103. 6.18 Dr. Reddy's
  104. 6.18.1 Dr. Reddy's Company Information
  105. 6.18.2 Dr. Reddy's Business Overview
  106. 6.18.3 Dr. Reddy's Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Dr. Reddy's Lansoprazole Product Portfolio
  108. 6.18.5 Dr. Reddy's Recent Developments
  109. 6.19 Cisen Pharmaceutical
  110. 6.19.1 Cisen Pharmaceutical Company Information
  111. 6.19.2 Cisen Pharmaceutical Business Overview
  112. 6.19.3 Cisen Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Cisen Pharmaceutical Lansoprazole Product Portfolio
  114. 6.19.5 Cisen Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Lansoprazole Sales by Country
  2. 7.1.1 North America Lansoprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lansoprazole Sales by Country (2021-2026)
  4. 7.1.3 North America Lansoprazole Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lansoprazole Market Size by Country
  6. 7.2.1 North America Lansoprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lansoprazole Market Size by Country (2021-2026)
  8. 7.2.3 North America Lansoprazole Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lansoprazole Sales by Country
  2. 8.1.1 Europe Lansoprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lansoprazole Sales by Country (2021-2026)
  4. 8.1.3 Europe Lansoprazole Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lansoprazole Market Size by Country
  6. 8.2.1 Europe Lansoprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lansoprazole Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lansoprazole Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lansoprazole Sales by Country
  2. 9.1.1 Asia-Pacific Lansoprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lansoprazole Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lansoprazole Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lansoprazole Market Size by Country
  6. 9.2.1 Asia-Pacific Lansoprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lansoprazole Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lansoprazole Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lansoprazole Sales by Country
  2. 10.1.1 South America Lansoprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lansoprazole Sales by Country (2021-2026)
  4. 10.1.3 South America Lansoprazole Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lansoprazole Market Size by Country
  6. 10.2.1 South America Lansoprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lansoprazole Market Size by Country (2021-2026)
  8. 10.2.3 South America Lansoprazole Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lansoprazole Sales by Country
  2. 11.1.1 Middle East and Africa Lansoprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lansoprazole Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lansoprazole Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lansoprazole Market Size by Country
  6. 11.2.1 Middle East and Africa Lansoprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lansoprazole Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lansoprazole Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lansoprazole Value Chain Analysis
  2. 12.1.1 Lansoprazole Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lansoprazole Production Mode & Process
  7. 12.2 Lansoprazole Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lansoprazole Distributors
  10. 12.2.3 Lansoprazole Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst